A

Atara Biotherapeutics
D

ATRA

5.72000
USD
-0.15
(-2.56%)
مغلق
حجم التداول
1,008
الربح لكل سهم
-9
العائد الربحي
-
P/E
-1
حجم السوق
33,512,959
أصول ذات صلة
C
CRVS
-0.21500
(-7.18%)
2.78000 USD
F
FATE
0.00800
(1.16%)
0.69810 USD
G
GLYC
-0.00270
(-1.48%)
0.18020 USD
R
RCKT
-0.39000
(-7.02%)
5.16500 USD
R
RGEN
-9.990
(-8.21%)
111.740 USD
T
TXG
-0.45000
(-5.65%)
7.52000 USD
V
VKTX
-1.820
(-7.51%)
22.420 USD
المزيد
الأخبار المقالات

العنوان: Atara Biotherapeutics Inc.

القطاع: Healthcare
الصناعة: Biotechnology
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).